IRFI-165

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameIRFI-165
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor antagonists
TargetsAdenosine A1 receptor
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiomedica Foscama
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomedica Foscama
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksN/A